Charles River Laboratories Provides Business Updates
WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) today announced two planned acquisitions of K.F. (Cambodia) Ltd. and PathoQuest SAS; the addition of Dr. Namandjé N. Bumpus as Chief Scientific and Innovat… [15844 chars]
Source: Business Wire | Published: 2026-01-12T21:30:00Z
Credit: Business Wire
